1,2,4-triazole derivatives as potential scaffold for anticonvulsant activity
- PMID: 25675400
- DOI: 10.2174/1871524915666150209100533
1,2,4-triazole derivatives as potential scaffold for anticonvulsant activity
Abstract
The search for new anticonvulsant agent with more selectivity and lower toxicity continues to be an area of rigorous investigation in medicinal chemistry. Epilepsy is a chronic disorder of brain whose treatment consists of controlling seizures with antiepileptic drugs that very often related with side-effects which in rare circumstances can be potentially life-threatening. Triazolam and Alprazolam are established drugs used in epilepsy which have triazole moiety. The potency and broad spectrum of the pharmacological response of triazole moiety as anticonvulsant agent have attracted the attention of medicinal chemists to explore this framework for its potential. The literature shows that different substitution on triazole ring exhibit potent antiepileptic activity with no or lesser neurotoxicity. The present review is a sincere attempt to compile the reported potent triazole derivatives with significant anticonvulsant action.
Similar articles
-
3,4-DHQLO and Triazole and Its Related Analogues with Anticonvulsant Effects.Mini Rev Med Chem. 2016;16(4):323-42. doi: 10.2174/1389557515666150101100909. Mini Rev Med Chem. 2016. PMID: 25553427 Review.
-
Recent developments on triazole nucleus in anticonvulsant compounds: a review.J Enzyme Inhib Med Chem. 2018 Dec;33(1):453-478. doi: 10.1080/14756366.2017.1423068. J Enzyme Inhib Med Chem. 2018. PMID: 29383949 Free PMC article. Review.
-
An Important Potential Anti-Epileptic/Anticonvulsant Active Group: A Review of 1,2,4-Triazole Groups and Their Action.Drug Res (Stuttg). 2022 Mar;72(3):131-138. doi: 10.1055/a-1670-6992. Epub 2021 Nov 10. Drug Res (Stuttg). 2022. PMID: 34758502 Review.
-
The importance of triazole scaffold in the development of anticonvulsant agents.Eur J Med Chem. 2016 Feb 15;109:380-92. doi: 10.1016/j.ejmech.2016.01.009. Epub 2016 Jan 11. Eur J Med Chem. 2016. PMID: 26826582 Review.
-
Quinazolines: new horizons in anticonvulsant therapy.Eur J Med Chem. 2014 Jun 10;80:447-501. doi: 10.1016/j.ejmech.2014.04.072. Epub 2014 Apr 28. Eur J Med Chem. 2014. PMID: 24813877 Review.
Cited by
-
2-[(3-Aminoalkyl-(alkaryl-,aryl-))-1H-1,2,4-triazol-5-yl]anilines: synthesis and anticonvulsant activity.Turk J Chem. 2020 Jun 1;44(3):746-755. doi: 10.3906/kim-2002-24. eCollection 2020. Turk J Chem. 2020. PMID: 33488191 Free PMC article.
-
Derivatives of a new heterocyclic system - pyrano[3,4-c][1,2,4]triazolo[4,3-a]pyridines: synthesis, docking analysis and neurotropic activity.Medchemcomm. 2019 Jun 19;10(8):1399-1411. doi: 10.1039/c9md00187e. eCollection 2019 Aug 1. Medchemcomm. 2019. PMID: 31534657 Free PMC article.
-
New Application of 1,2,4-Triazole Derivatives as Antitubercular Agents. Structure, In Vitro Screening and Docking Studies.Molecules. 2020 Dec 19;25(24):6033. doi: 10.3390/molecules25246033. Molecules. 2020. PMID: 33352814 Free PMC article.
-
Synthesis and Biological Activities of Ethyl 2-(2-pyridylacetate) Derivatives Containing Thiourea, 1,2,4-triazole, Thiadiazole and Oxadiazole Moieties.Molecules. 2017 Mar 6;22(3):409. doi: 10.3390/molecules22030409. Molecules. 2017. PMID: 28272311 Free PMC article.
-
Discovery of novel dual adenosine A1/A2A receptor antagonists using deep learning, pharmacophore modeling and molecular docking.PLoS Comput Biol. 2021 Mar 19;17(3):e1008821. doi: 10.1371/journal.pcbi.1008821. eCollection 2021 Mar. PLoS Comput Biol. 2021. PMID: 33739970 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources